Presentations & Publications
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells
Concarlo in the News
US biotech start-up set to have huge impact on breast cancer treatment landscape
Concarlo: targeting proliferation and resistance in one go
Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer
Women & Wealth Magazine: 18 Women to Watch in 2018
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
